X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

AQST

Closed

Aquestive Therapeutics Inc

3.4
+0.1 (+3.02%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 3.31
Day's Range: 3.28 - 3.505
Send
When Written:
 
1.14
Aquestive Therapeutics Inc. is a pharmaceutical company that specializes in developing and commercializing differentiated products to address unmet medical needs. The company was founded in 2004 and is headquartered in Warren, New Jersey. Aquestive Therapeutics focuses on developing products for central nervous system (CNS) diseases, such as epilepsy, migraine, and Parkinson's disease, as well as for other medical conditions, including allergies and inflammation.

The company's proprietary technology platform, PharmFilm®, allows for the rapid delivery of drugs through the oral mucosa, providing an alternative to traditional oral dosage forms. This technology has been used to develop several products, including Sympazan® (clobazam) oral film for the treatment of seizures associated with Lennox-Gastaut syndrome, and Suboxone® (buprenorphine and naloxone) sublingual film for the treatment of opioid dependence.

Aquestive Therapeutics is also involved in partnerships and collaborations with other pharmaceutical companies, academic institutions, and research organizations to advance the development of its products. The company is publicly traded on the NASDAQ stock exchange under the ticker symbol AQST.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X